ELIZABETH LEMKE: Open Payments
NPI 1730412784 · FISHKILL, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,061 in 28 payments from 13 companies in 2025. Trend: 2023 $1,874 · 2024 $816 · 2025 $1,061
Food & beverage: $1,061
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 5 | $163 |
| Lilly USA, LLC | 3 | $155 |
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| Alkermes, Inc. | 1 | $123 |
| Neurocrine BioSciences, Inc. | 1 | $110 |
| Exact Sciences Corporation | 5 | $107 |
| Antares Pharma, Inc. | 5 | $95 |
| Boston Scientific Corporation | 1 | $58 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $36 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $31 |
Products named: REXULTI, ZEPBOUND, BREZTRI, LYBALVI, INGREZZA, Cologuard Collection Kit, XYOSTED, General - Pain Management.
Industry payments across NY — which companies pay providers there.
